Viatris Total Long-Term Assets 2010-2024 | VTRS

Viatris total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
  • Viatris total long-term assets for the quarter ending September 30, 2024 were $33.446B, a 11.54% decline year-over-year.
  • Viatris total long-term assets for 2023 were $34.709B, a 11.88% decline from 2022.
  • Viatris total long-term assets for 2022 were $39.387B, a 10.36% decline from 2021.
  • Viatris total long-term assets for 2021 were $43.94B, a 9.75% decline from 2020.
Viatris Annual Total Long-Term Assets
(Millions of US $)
2023 $34,709
2022 $39,387
2021 $43,940
2020 $48,686
2019 $24,498
2018 $26,367
2017 $28,593
2016 $27,204
2015 $15,795
2014 $9,379
2013 $10,824
2012 $8,029
2011 $8,029
2010 $7,977
2009 $7,516
Viatris Quarterly Total Long-Term Assets
(Millions of US $)
2024-09-30 $33,446
2024-06-30 $33,538
2024-03-31 $34,420
2023-12-31 $34,709
2023-09-30 $37,811
2023-06-30 $38,917
2023-03-31 $39,660
2022-12-31 $39,387
2022-09-30 $38,175
2022-06-30 $39,949
2022-03-31 $41,723
2021-12-31 $43,940
2021-09-30 $44,762
2021-06-30 $46,234
2021-03-31 $46,661
2020-12-31 $48,686
2020-09-30 $23,908
2020-06-30 $23,691
2020-03-31 $23,545
2019-12-31 $24,498
2019-09-30 $24,408
2019-06-30 $25,552
2019-03-31 $25,644
2018-12-31 $26,367
2018-09-30 $26,914
2018-06-30 $26,974
2018-03-31 $28,423
2017-12-31 $28,593
2017-09-30 $28,552
2017-06-30 $28,540
2017-03-31 $27,207
2016-12-31 $27,204
2016-09-30 $28,573
2016-06-30 $16,650
2016-03-31 $16,017
2015-12-31 $15,795
2015-09-30 $14,831
2015-06-30 $14,903
2015-03-31 $14,697
2014-12-31 $9,379
2014-09-30 $9,356
2014-06-30 $11,126
2014-03-31 $11,013
2013-12-31 $10,824
2013-09-30 $8,558
2013-06-30 $7,999
2013-03-31 $7,935
2012-12-31 $8,029
2012-09-30 $7,956
2012-06-30 $7,850
2012-03-31 $8,195
2011-12-31 $8,029
2011-09-30 $7,509
2011-06-30 $8,246
2011-03-31 $8,121
2010-12-31 $7,977
2010-09-30 $7,944
2010-06-30 $6,968
2010-03-31 $7,468
2009-12-31 $7,516
2009-09-30 $7,501
2009-06-30 $7,220
2009-03-31 $6,984
Sector Industry Market Cap Revenue
Medical Medical Services $15.576B $15.427B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
Charles River Laboratories (CRL) United States $9.516B 18.39
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00